Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Dose Adjustments for High Fat Meals in T1DM
NCT02595658Completed
- Sponsor
- Northumbria University
- Start
- Nov 2014
- Primary completion
- Jul 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
Randomised, open-label trial of insulin lispro, insulin aspart and insulin glulisine in type 1 diabetes mellitus (T1D), sponsored by Northumbria University. Started Nov 2014; status: completed.
02
Drugs
insulin lisproinsulin aspartinsulin glulisine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02595658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02595658.